Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis

NCT00391976 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis